These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8027006)

  • 1. Resistance of Pseudomonas aeruginosa to isothiazolone.
    Brözel VS; Cloete TE
    J Appl Bacteriol; 1994 Jun; 76(6):576-82. PubMed ID: 8027006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane protein shifts in biocide-resistant Pseudomonas aeruginosa PAO1.
    Winder CL; Al-Adham IS; Abdel Malek SM; Buultjens TE; Horrocks AJ; Collier PJ
    J Appl Microbiol; 2000 Aug; 89(2):289-95. PubMed ID: 10971761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of Pseudomonas aeruginosa to 2,2'-methylenebis (4-chlorophenol).
    Brözel VS; Cloete TE
    J Appl Bacteriol; 1993 Jan; 74(1):94-9. PubMed ID: 8420922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics.
    Loughlin MF; Jones MV; Lambert PA
    J Antimicrob Chemother; 2002 Apr; 49(4):631-9. PubMed ID: 11909837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.
    Tateda K; Ishii Y; Hirakata Y; Matsumoto T; Ohno A; Yamaguchi K
    J Antimicrob Chemother; 1994 Dec; 34(6):931-42. PubMed ID: 7730236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility changes and T-OMP shifts in pyrithione-passaged planktonic cultures of Pseudomonas aeruginosa PAO1.
    Abdel-Malek SM; Al-Adham IS; Winder CL; Buultjens TE; Gartland KM; Collier PJ
    J Appl Microbiol; 2002; 92(4):729-36. PubMed ID: 11966914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adaptation process of Pseudomonas aeruginosa to didecyldimethylammonium chloride in 2-propanol on bactericidal efficiency of this active substance.
    Chojecka A; Wiercińska O; Röhm-Rodowald E; Kanclerski K; Jakimiak B
    Rocz Panstw Zakl Hig; 2014; 65(4):359-64. PubMed ID: 25526583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sub-inhibitory concentrations of antibiotics on surface expression of ferripyochelin-binding protein in Pseudomonas aeruginosa.
    LeVatte MA; Sokol PA
    J Antimicrob Chemother; 1989 Dec; 24(6):881-95. PubMed ID: 2559913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
    Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
    J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
    Gilleland LB; Gilleland HE; Gibson JA; Champlin FR
    J Med Microbiol; 1989 May; 29(1):41-50. PubMed ID: 2498520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin.
    Maloney J; Rimland D; Stephens DS; Terry P; Whitney AM
    Arch Intern Med; 1989 Mar; 149(3):630-4. PubMed ID: 2493230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuous exposure to ciprofloxacin on the outer membrane of P. aeruginosa.
    Magni A; Giordano A; Papa F; de Vito D; Cipriani P
    New Microbiol; 1994 Oct; 17(4):307-12. PubMed ID: 7861986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
    Cipriani P; Giordano A; Magni A; Papa F; Filadoro F
    Drugs Exp Clin Res; 1995; 21(4):139-44. PubMed ID: 8529526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
    Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic stress induces a large amount of outer membrane protein in Pseudomonas aeruginosa.
    Nakajima A; Hoshikawa M; Nakae T
    FEMS Microbiol Lett; 1998 Aug; 165(2):261-5. PubMed ID: 9742697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane changes in quinolone resistant Pseudomonas aeruginosa.
    Hashmi ZS; Smith JM
    J Antimicrob Chemother; 1991 Sep; 28(3):465-70. PubMed ID: 1660047
    [No Abstract]   [Full Text] [Related]  

  • 18. Imipenem resistance in Pseudomonas aeruginosa is due to diminished expression of outer membrane proteins.
    Büscher KH; Cullmann W; Dick W; Wendt S; Opferkuch W
    J Infect Dis; 1987 Oct; 156(4):681-4. PubMed ID: 3114392
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of transcriptomes of wild-type and isothiazolone-resistant Pseudomonas aeruginosa by using RNA-seq.
    Zhou G; Shi QS; Huang XM; Xie XB
    Mol Biol Rep; 2016 Jun; 43(6):527-40. PubMed ID: 27072374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
    Shen JL; Fang YP
    Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.